Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| POLARIS VENTURE MANAGEMENT CO V LLC | 08-12-2021 | 06-30-2021 | 7 | 62,416,000 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| Fate Therapeutics, Inc. | Common Stock | 1 | $49,461,000 | 569,889 | 79.24 | 60.92 | 0 | 0.00 | 06-30-2021 |
| Lyra Therapeutics, Inc. | Common Stock | 2 | $8,840,000 | 1,100,852 | 14.16 | 16.54 | 0 | 0.00 | 06-30-2021 |
| x4 Pharmaceuticals Inc. | Common Stock | 3 | $2,025,000 | 311,492 | 3.24 | 3.48 | 0 | 0.00 | 06-30-2021 |
| Atyr Pharma Inc. | Common Stock | 4 | $637,000 | 130,572 | 1.02 | 0.75 | 0 | 0.00 | 06-30-2021 |
